Skip to main content
. 2019 Jul 23;14(7):e0219474. doi: 10.1371/journal.pone.0219474

Table 4. Test outcomes when using non-rigorous sample inclusion criteria.

a) Anti-ZIKV-IgM-positive (n = 22) Anti-ZIKV-IgM-negative (n = 102) b) Anti-ZIKV-IgG-positive (n = 24) Anti-ZIKV-IgG-negative (n = 84)
Acute-LFRET positive 100% (n = 22) 4% (n = 4) Immunity-LFRET positive 83% (n = 20) 0% (n = 0)
Acute-LFRET negative 0% (n = 0) 96% (n = 98) Immunity-LFRET negative 17% (n = 4) 100% (n = 84)

a) Acute-LFRET outcomes vs. IgM-reference tests

b) Immunity-LFRET outcomes vs. IgG-reference tests